Related Experiment Video
Updated: Jan 17, 2026

Author Spotlight: Self-Assessment Protocol for Predicting Psoriatic Arthritis in Psoriasis Patients
Published on: March 1, 2024
Ocular Comorbidities of Psoriasis: A Systematic Review and Meta-analysis of Observational Studies
Ching-Ya Wang1, Tzu-Yi Lin2, Tzu- Yu Wang3
1From the Department of Dermatology (C.Y.W.), Taipei City Hospital, Taipei, Taiwan.
Topic:
Ocular comorbidities of psoriasis: A systematic review and meta-analysis of observational studies.
Design:
Systematic review and meta-analysis.
Clinical Relevance:
Ocular comorbidities of psoriasis have been raised with growing evidence. Certain eye diseases require prompt diagnosis and appropriate interventions, otherwise irreversible blindness may occur.
Methods:
We searched PubMed, MEDLINE, Embase, Cochrane Central Register of Controlled Trials (CENTRAL) databases from their respective inception to August 15, 2025. Observational studies providing data on risk estimates for eye diseases, such as cataract, uveitis, dry eye disease, glaucoma, retinal vein occlusion, conjunctivitis, meibomian gland dysfunction and blepharitis, between patients with psoriasis and without psoriasis were included. Newcastle-Ottawa scale was utilized to evaluate the risk of bias. A random-effects model meta-analysis was conducted. Our primary outcomes were the risk estimates of ocular comorbidities in patients with psoriasis. This study is registered in the Open Science Framework (https://osf.io/tkn92).
Results:
We included 34 studies involving 10 045 036 subjects. Patients with psoriasis showed increased risk of cataract (hazard ratio [HR] 1.78, 95% confidence interval [CI] 1.53-2.07), uveitis (HR: 1.65, 95% CI: 1.35-2.01 [cohort studies]; odds ratio [OR] 2.56, 95% CI: 1.60-4.10 [case-control studies]), dry eye disease (OR: 5.01, 95% CI: 2.31-10.86), glaucoma (HR: 1.40, 95% CI: 1.05-1.88), retinal vein occlusion (HR: 1.58, 95% CI: 1.23-2.03), conjunctivitis (OR: 3.76, 95% CI: 1.33-10.63), meibomian gland dysfunction (OR: 4.45, 95% CI: 1.9-10.40), and blepharitis (OR: 2.28, 95% CI: 1.24-4.19).
Conclusions:
The current evidence reveals associations of psoriasis with cataract, uveitis, dry eye disease, glaucoma, retinal vein occlusion, conjunctivitis, meibomian gland dysfunction and blepharitis. Ophthalmic consultation should be sought for psoriasis patients presenting ocular symptoms for prompt diagnosis and appropriate intervention.
Related Concept Videos
Glaucoma: Overview
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Medical History
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...

